Evidence map›Paper›PMID 38632538›Full record

ArticleBMC genomics2024

Respiratory carriage of hypervirulent Klebsiella pneumoniae by indigenous populations of Malaysia.

Souradeep Das, Anish K Pandey, Denise E Morris, Rebecca Anderson, Victor Lim, Chong Chun Wie, Ivan Kok Seng Yap, Ahmed Ghazi Alattraqchi, Hafis Simin, Ramle Abdullah and 3 more

Abstract read
In one paragraph

Article in BMC genomics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Souradeep DasFaculty of Medicine, Institute for Life Sciences, University of Southampton, Southampton, UK.
Anish K PandeyFaculty of Medicine, Institute for Life Sciences, University of Southampton, Southampton, UK.
Denise E MorrisFaculty of Medicine, Institute for Life Sciences, University of Southampton, Southampton, UK.
Rebecca AndersonFaculty of Medicine, Institute for Life Sciences, University of Southampton, Southampton, UK.
Victor LimSchool of Medicine, International Medical University, Kuala Lumpur, Malaysia.
Chong Chun WieInstitute for Research, Development and Innovation, International Medical University, Kuala Lumpur, Malaysia.
Ivan Kok Seng YapSchool of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia.
Ahmed Ghazi AlattraqchiCentre for Research in Infectious Diseases and Biotechnology (CeRIDB), Faculty of Medicine, Universiti Sultan Zainal Abidin, Medical Campus, 20400, Kuala Terengganu, Terengganu, Malaysia.
Hafis SiminFaculty of Applied Social Sciences, Universiti Sultan Zainal Abidin, Gong Badak Campus, 21300, Kuala Nerus, Terengganu, Malaysia.
Ramle AbdullahCentre of Excellence in National Indigenous Pedagogy, Institute of Teacher Education Tengku, Ampuan Afzan Campus, Pahang, Malaysia.
Chew Chieng YeoCentre for Research in Infectious Diseases and Biotechnology (CeRIDB), Faculty of Medicine, Universiti Sultan Zainal Abidin, Medical Campus, 20400, Kuala Terengganu, Terengganu, Malaysia.ORCID http://orcid.org/0000-0002-9644-6925
Stuart C ClarkeFaculty of Medicine, Institute for Life Sciences, University of Southampton, Southampton, UK.ORCID http://orcid.org/0000-0002-7009-1548
David W ClearyInstitute of Microbiology and Infection, College of Medical and Dental Sciences, University of Birmingham, University of Birmingham, UK. d.w.cleary@bham.ac.uk.ORCID http://orcid.org/0000-0003-4533-0700

Funding

International Medical University BP I-01/12 (09) 2015Newton Fund Institutional Links 172686537
6 · The paper itself

Abstract

Klebsiella pneumoniae is a Gram-negative Enterobacteriaceae that is classified by the World Health Organisation (WHO) as a Priority One ESKAPE pathogen. South and Southeast Asian countries are regions where both healthcare associated infections (HAI) and community acquired infections (CAI) due to extended-spectrum β-lactamase (ESBL)-producing and carbapenem-resistant K. pneumoniae (CRKp) are of concern. As K. pneumoniae can also exist as a harmless commensal, the spread of resistance genotypes requires epidemiological vigilance. However there has been no significant study of carriage isolates from healthy individuals, particularly in Southeast Asia, and specially Malaysia. Here we describe the genomic analysis of respiratory isolates of K. pneumoniae obtained from Orang Ulu and Orang Asli communities in Malaysian Borneo and Peninsular Malaysia respectively. The majority of isolates were K. pneumoniae species complex (KpSC) 1 K. pneumoniae (n = 53, 89.8%). Four Klebsiella variicola subsp. variicola (KpSC3) and two Klebsiella quasipneumoniae subsp. similipneumoniae (KpSC4) were also found. It was discovered that 30.2% (n = 16) of the KpSC1 isolates were ST23, 11.3% (n = 6) were of ST65, 7.5% (n = 4) were ST13, and 13.2% (n = 7) were ST86. Only eight of the KpSC1 isolates encoded ESBL, but importantly not carbapenemase. Thirteen of the KpSC1 isolates carried yersiniabactin, colibactin and aerobactin, all of which harboured the rmpADC locus and are therefore characterised as hypervirulent. Co-carriage of multiple strains was minimal. In conclusion, most isolates were KpSC1, ST23, one of the most common sequence types and previously found in cases of K. pneumoniae infection. A proportion were hypervirulent (hvKp) however antibiotic resistance was low.

Indexed as

Klebsiella InfectionsKlebsiella pneumoniaeAnti-Bacterial Agentsbeta-LactamasesCarbapenemsHumansIndigenous PeoplesMalaysiaVirulenceAnti-Bacterial Agentsbeta-LactamasesCarbapenemsAntimicrobial resistanceESBLHypervirulentKlebsiella pneumoniaeMalaysia

Identifiers

PMID38632538
PMCPMC11025145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.